ROBERT ZALEWSKI-ZARAGOZA: Open Payments
NPI 1720054133 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$29,186 in 43 payments from 7 companies in 2025. Trend: 2023 $355 · 2024 $615 · 2025 $29,186
Speaker / faculty: $26,070Travel & lodging: $1,599Food & beverage: $1,517
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 31 | $28,648 |
| E.R. Squibb & Sons, L.L.C. | 4 | $210 |
| Neurocrine BioSciences, Inc. | 1 | $154 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| Lundbeck LLC | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: SPRAVATO, COBENFY, INGREZZA, REXULTI, FANAPT, Auvelity.
Industry payments across CA — which companies pay providers there.
